Therapeutic Treatment Planning Flashcards
7 cards from real NAPLEX QBANK practice questions. Tap to flip, then mark Knew It or Still Learning โ missed cards come back until you master them.
Read the first 7 Therapeutic Treatment Planning flashcards as text
A patient with major depressive disorder and significant insomnia and poor appetite would benefit most from which antidepressant?
Answer: Mirtazapine
Mirtazapine promotes sleep and increases appetite, making it well suited for depressed patients with insomnia and weight loss.
A patient with COPD has 3 exacerbations in the past year despite a LABA/LAMA combination. What is the best step in the treatment plan?
Answer: Add an inhaled corticosteroid
Frequent exacerbations on dual bronchodilator therapy support escalation to triple therapy by adding an inhaled corticosteroid.
Which empiric antibiotic regimen is most appropriate for an otherwise healthy adult outpatient with community-acquired pneumonia and no comorbidities or recent antibiotics?
Answer: Amoxicillin or doxycycline
Healthy outpatients with CAP and no comorbidities can be treated with amoxicillin or doxycycline monotherapy.
A patient with gout has 3 attacks per year and a serum urate of 9 mg/dL. After acute treatment, what is the appropriate long-term plan?
Answer: Start allopurinol with a urate target below 6 mg/dL
Recurrent gout with elevated urate warrants urate-lowering therapy such as allopurinol titrated to a target below 6 mg/dL.
A patient with stable angina remains symptomatic on maximally tolerated metoprolol. Which addition is most appropriate?
Answer: A dihydropyridine calcium channel blocker
Adding a dihydropyridine calcium channel blocker to a beta-blocker provides additional antianginal control in stable angina.
A patient with hypothyroidism on levothyroxine has a persistently elevated TSH despite good adherence. Which medication taken concurrently most likely impairs absorption?
Answer: Calcium carbonate
Calcium carbonate binds levothyroxine and reduces its absorption, so the two should be separated by several hours.
Which treatment plan adjustment is most appropriate for a patient with type 2 diabetes and established atherosclerotic cardiovascular disease already on metformin?
Answer: Add a GLP-1 receptor agonist with proven cardiovascular benefit
In type 2 diabetes with ASCVD, a GLP-1 receptor agonist with proven cardiovascular benefit is recommended regardless of A1c.